{"id":"W2990041408","doi":"10.1056/nejmoa1913662","title":"Overall Survival with Osimertinib in Untreated, <i>EGFR</i> -Mutated Advanced NSCLC","year":2019,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2816,"is_retracted":false,"has_abstract":true,"ca_institutions":"William Osler Health System; University of Toronto","funders":"AstraZeneca","keywords":"Osimertinib; T790M; Medicine; Oncology; Epidermal growth factor receptor; Lung cancer; Gefitinib; Internal medicine; Hazard ratio; Progression-free survival; Tyrosine kinase; Cancer research; Overall survival; Cancer; Erlotinib; Receptor; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00189186,0.0004790428,0.001128401,0.000334845,0.0001927451,0.0005122044,0.0004128735,0.000655996,0.001640473],"category_scores_gemma":[0.001579564,0.0001810559,0.001437646,0.0002970205,0.0005390846,0.0005800408,0.000358921,0.001121238,0.000137412],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008118345,"about_ca_system_score_gemma":0.0005729811,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005542331,"about_ca_topic_score_gemma":0.0009228267,"domain_scores_codex":[0.9993474,0.0003379526,0.00005340383,0.0001046112,0.00007002871,0.00008659077],"domain_scores_gemma":[0.9992478,0.0002316683,0.0002097986,0.00003551857,0.00002813276,0.0002470722],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8885818,0.005874343,0.0170587,0.0006406592,0.001468018,0.0001460061,0.000146728,0.004655515,0.007060477,0.0002116475,0.00119238,0.07296367],"study_design_scores_gemma":[0.2872429,0.6021781,0.09664608,0.0001820796,0.002627028,0.0003498121,0.0001032033,0.003895603,0.003113823,0.0008823638,0.002729761,0.0000493216],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968001,0.002025023,0.0001213735,0.0001210484,0.00007231355,0.00009730693,0.0001452895,0.000009402757,0.0006081609],"genre_scores_gemma":[0.9983406,0.0007550159,0.00009422038,0.0001277155,0.00007834307,0.0001279928,0.0002671157,0.00000283172,0.0002062953],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00189186,"threshold_uncertainty_score":0.01000524,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008928424385361516,"score_gpt":0.2917111297997033,"score_spread":0.2827827054143418,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}